Gilead boosts planned U.S. investments by $11 billion amid tariff threat
On May 7, 2025, Gilead Sciences announced $11 billion in new planned investment in the U.S. to add…
On May 7, 2025, Gilead Sciences announced $11 billion in new planned investment in the U.S. to add…
On My 7, 2025, researchers at the University College London (UCL) and King’s College London announced that an…
On May 7, 2025, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have published…
On May 6, 2025, UT Southwestern Medical Center and Children’s Health℠ announced a historic nine-figure grant from the Moody Foundation…
On May 5, 2025, The European Union (EU) and France announced half a billion euros worth of incentives…
On My 2, 2025, researchers at the Wellcome Sanger Institute, UCL, and the University of Cambridge announced they…
On May 2, 2025, the Centers for Disease Control reported twelve pediatric deaths associated with seasonal influenza virus…
On May 1, 2025, the staff members at the U.S. National Science Foundation (NSF) were told to “stop…
On Apr. 30, 2025, Regulus Therapeutics announced that it has entered into an agreement and plan of merger…
On Apr. 29, 2025, Merck announced the start of construction for a $1 billion, 470,000 square-foot state-of-the-art biologics…
On Apr. 29, 2025, BioMADE announced Maple Grove as the Minnesota site in its national network of bioindustrial…
On Apr. 28, 2025, researchers at King’s College London, the University of Bristol and Great Ormond Street Hospital…
On Apr. 28, 2025, Merck and SpringWorks Therapeutics announced the companies have entered into a definitive agreement for…
On Apr. 26, 2025, the World Health Organization (WHO) reported that Uganda has declared the end of the…
On Apr. 25, 2025, Amgen announced a $900 million expansion of its Ohio biotech manufacturing facility in New…
On Apr. 25, 2025, University of Washington announced that the Memory & Brain Wellness Center at Harborview Medical…
On Apr. 22, 2025, Syngenta announced that its next-generation insecticide Sovrenta® has received pre-qualification by World Health Organization…
On Apr. 22, 2025, Regeneron Pharmaceuticals announced a significant expansion of its manufacturing capacity through a new agreement…
On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…
On Apr. 17, 2025, research-integrity analysts are warning that ‘journal snatchers’ — companies that acquire scholarly journals from…
On Apr. 17, 2025, researchers from the University of of Pittsburgh announced they have produced the most detailed…
On Apr. 14, 2025, a new University of Southern California (USC) study suggests that gut imbalances in children…
On Apr. 14, 2025, a research team at the Institute for Basic Science (IBS) in Korea announced they…
On Apr. 11, 2025, Africa’s top public health institution announced it is planning to tap more funds from…
On Apr. 11, 2025, the UK National Institute for Health and Care Excellence (NICE) recommended capivasertib (also called…
On Apr. 10, 2025, the World Health Organization (WHO) published its first-ever global guidelines for meningitis diagnosis, treatment…
On Apr. 10, 2025, the U.S. Food and Drug Administration announced it is taking a groundbreaking step to…
On Apr. 10, 2025, Novartis, a leading global innovative medicines company, announced a planned $23 billion investment over…
On Apr. 9, 2025, a team of neuro scientists scientists published findings from the Machine Intelligence from Cortical…
On Apr. 9, 2025, Roswell Park Comprehensive Cancer Center achieved textbook outcomes for 90% of 150 consecutive robot-assisted,…